ArticleAnnals of hematology2025

Daratumumab plus bortezomib and dexamethasone as a bridge to allogeneic transplantation in refractory T-cell lymphoblastic lymphoma.

Alessio Maria Edoardo Maraglino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.